Company Filing History:
1 out of 704 
1 out of 595 
1 out of 65 
Years Active: 2026
Title: Gregory Cuny - Innovator in Cell Signaling Inhibition
Introduction
Gregory Cuny is an inventor based in Houston, TX (US). He has made significant contributions to the field of cell signaling inhibition. Although he currently holds no granted patents, his work is noteworthy for its potential applications in medical treatments.
Latest Patent Applications
Gregory Cuny's latest patent application is titled "RIPK2 AND NOD INHIBITORS." This application discloses substituted phenylpyridine compounds and their use in methods of treatment. The compounds are designed for inhibiting RIPK2 and/or NOD2 cell signaling, which could have important implications for therapeutic interventions.
Conclusion
Gregory Cuny's innovative work in the area of cell signaling inhibition highlights his potential as an inventor in the medical field. His contributions may pave the way for future advancements in treatment methodologies.